Semi-Annual Statement Of Income And Retained Earnings

STELLA PHARMA CORPORATION - Filing #7350910

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-466,969,000 JPY
-503,005,000 JPY
Non-operating income
Non-operating income
4,237,000 JPY
26,084,000 JPY
Non-operating expenses
Non-operating expenses
3,922,000 JPY
3,577,000 JPY
Ordinary profit (loss)
-466,654,000 JPY
-480,498,000 JPY
Extraordinary losses
Extraordinary losses
768,000 JPY
JPY
Profit (loss) before income taxes
-467,422,000 JPY
-480,498,000 JPY
Income taxes - current
2,138,000 JPY
2,722,000 JPY
Profit (loss)
-469,561,000 JPY
-483,220,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.